AMAG buying once-bankrupt Lumara for up to $1bn
This article was originally published in Scrip
Executive Summary
AMAG Pharmaceuticals has been on the lookout for assets to add to its bag of marketed products for the past few years and now the company will pay up to $1bn to buy Lumara Health, formerly KV Pharmaceutical, which emerged from bankruptcy a year ago.